Recursion Pharmaceuticals
Shadi Swaidani is a highly experienced Principal Scientist in Immunology and Oncology at Recursion since 2022, and has been a member of the Case Comprehensive Cancer Center since 2018. Prior experience includes serving as a Staff Scientist and Associate Research Scientist at Cleveland Clinic from 2018 to 2022 and 2010 to 2014, respectively, as well as a Postdoctoral Research Fellow. Shadi Swaidani was a Molecular Medicine Scholar at Howard Hughes Medical Institute from June 2007 to July 2010 and completed graduate studies at Cleveland Clinic Lerner College of Medicine. Educational qualifications include degrees from Case Western Reserve University, Cleveland Clinic Lerner College of Medicine, and The Ohio State University.
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.